Epratuzumab
|
WikiDoc Resources for Epratuzumab |
|
Articles |
|---|
|
Most recent articles on Epratuzumab Most cited articles on Epratuzumab |
|
Media |
|
Powerpoint slides on Epratuzumab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Epratuzumab at Clinical Trials.gov Clinical Trials on Epratuzumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Epratuzumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Epratuzumab Discussion groups on Epratuzumab Patient Handouts on Epratuzumab Directions to Hospitals Treating Epratuzumab Risk calculators and risk factors for Epratuzumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Epratuzumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus (SLE).
See also
Template:Humanizedmonoclonals Template:WH Template:WikiDoc Sources